flow trial semaglutide chronic kidney disease results 2024 Long-term outcomes of in obesity and cardiovascular in the SELECT FLOW Trial Shows Benefit of
Description
Make an informed decision about whether and how to incorporate GLP-1s into your employee benefits strategy, with insights from our chief medical officer.
A new study has reported that a novel member from a class of anti-diabetes drug could be used to treat a muscle wasting disease by suppressing inflammation.
Once opened, use as soon as possible
The best tasting, healthy Weight Watchers recipes including macros and WW Points for weight loss
Over 30 million Americans are using medications like Wegovy and Ozempic, but surgeons say rapid muscle loss is causing an unexpected side effect: back pain.
